Health

BPGbio Appoints John Dvor as Executive Vice President, Corporate Development

BOSTON, Nov. 11, 2025 (GLOBE NEWSWIRE) -- BPGbio, Inc., a biology-first, AI-powered, clinical-stage biopharma focused on mitochondrial biology and protein…

1 month ago

Vieworks Completes Major Expansion of Hwaseong Manufacturing Site, Doubling Production Capacity

Strategic Infrastructure Growth Positions Vieworks at the Forefront of Global Imaging Innovation ANYANG, South Korea, Nov. 12, 2025 /PRNewswire/ --…

1 month ago

The Sigourney Award-2025 Celebrates Four Recipients Honored for Creative Trailblazing Work Expanding Psychoanalytic Thought Globally

Interdisciplinary Work from Israel, Uruguay, and the United States Earns The Prestigious Sigourney Award-2025 Prize SAN FRANCISCO, Nov. 11, 2025…

1 month ago

SMT Celebrates 20 Years of the Cocoon Occluder Journey, Transforming Lives in Congenital and Structural Heart Defects

Congenital Heart Disease (CHD) is one of the most common birth defects, affecting approximately 1% of live births globally and…

1 month ago

Vor Bio Announces Pricing of Public Offering of $100 Million of Common Stock

November 10, 2025 21:56 ET  | Source: Vor Biopharma BOSTON, Nov. 10, 2025 (GLOBE NEWSWIRE) -- Vor Biopharma Inc. (Nasdaq:…

1 month ago

Canadian Red Cross sending emergency medical clinic to Jamaica

Humanitarian experts deploying to help people impacted by Hurricane Melissa November 10, 2025 18:22 ET  | Source: Canadian Red Cross…

1 month ago

TraceLink Customers Demonstrate Readiness as DSCSA Dispenser Deadline Arrives

TraceLink Continues to Set the Standard for United States Drug Supply Chain Security (DSCSA) Leadership, Proven by Real-World Success, Industry…

1 month ago

Halia Therapeutics to Present Groundbreaking Data on Novel Allosteric NEK7 Inhibitor Ofirnoflast at the 2025 American Society of Hematology Annual Meeting

- Data demonstrates ofirnoflast's efficacy in myelodysplastic syndrome (MDS) with robust and sustained hematologic responses – - A novel mechanism…

1 month ago

GENFIT Enters Research Collaboration with EVerZom to Advance Exosome-based Regenerative Technology in ACLF

EVerZom’s investigational drug candidate EViv, developed to treat ACLF, using its proprietary exosome platform, represents a novel approach to regenerative…

1 month ago

GENFIT Presents Promising New Preclinical Data on NTZ/G1090N for the Treatment of ACLF at The Liver Meeting 2025

Preclinical studies demonstrated significant efficacy on systemic inflammation and organ function in ACLF disease modelsSafety data from Phase 1 on…

1 month ago